Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease.
Niitsu T, Fukushima K, Komukai S, Takata S, Abe Y, Nii T, Kuge T, Iwakoshi S, Shiroyama T, Miyake K, Tujino K, Tanizaki S, Iwahori K, Hirata H, Miki K, Yanagawa M, Takeuchi N, Takeda Y, Kida H, Kumanogoh A.
Niitsu T, et al.
RMD Open. 2023 Jan;9(1):e002667. doi: 10.1136/rmdopen-2022-002667.
RMD Open. 2023.
PMID: 36690385
Free PMC article.